Cargando…
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
BACKGROUND: We previously reported that intrathecal injection of lysophosphatidylcholine (LPC) induced neuropathic pain through activation of the lysophosphatidic acid (LPA)-1 receptor, possibly via conversion to LPA by autotaxin (ATX). RESULTS: We examined in vivo LPA-induced LPA production using a...
Autores principales: | Ma, Lin, Uchida, Hitoshi, Nagai, Jun, Inoue, Makoto, Chun, Jerold, Aoki, Junken, Ueda, Hiroshi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780384/ https://www.ncbi.nlm.nih.gov/pubmed/19912636 http://dx.doi.org/10.1186/1744-8069-5-64 |
Ejemplares similares
-
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008) -
Autotaxin and lysophosphatidic acid(1 )receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine
por: Nagai, Jun, et al.
Publicado: (2010) -
Molecular mechanism of lysophosphatidic acid-induced hypertensive response
por: Kano, Kuniyuki, et al.
Publicado: (2019) -
Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014) -
Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018)